1315 Capital (Philadelphia, PA)
Adele founded 1315 Capital in 2014 to establish a firm focused on healthcare growth investing. She was recruited to Quaker Partners in 2007 to expand their growth and expansion stage investing practice. Prior to Quaker, Adele was Co-Head of US Healthcare at Apax Partners, a global private equity firm, where she started in 1997.
Forbes has recognized Ms Oliva on its Midas Touch list of top 100 technology investors worldwide (2012), top 10 life science investors (2013) and top women in venture capital (2012, 2013, 2014). Adele has served on the board of many high growth companies including Ascent Healthcare Solutions (acquired by Stryker), EKR Therapeutics (acquired by Cornerstone Therapeutics), ESP Pharma (acquired by Protein Design Labs), Esprit Pharma (acquired by Allergan) and Prometheus Labs (acquired by Nestle).
Prior to entering private equity as a Kauffman Fellow in 1997, Adele built a strong foundation in finance and healthcare at CoreStates in commercial banking and Baxter Healthcare in marketing and business development. Adele received a BSc from St. Joseph's University and an MBA from Cornell University, where she was awarded the Albert Fried Fellowship.